Related Experiment Videos
Treatment adherence in hemophilia
Courtney D Thornburg1, Natalie A Duncan2
1Hemophilia and Thrombosis Treatment Center, Rady Children's Hospital, San Diego, CA.
Patient Preference and Adherence
|October 17, 2017
Summary
Adherence to prophylactic clotting-factor regimens is crucial for preventing bleeds and preserving joint health in hemophilia patients. Personalized strategies and new extended half-life factors may improve patient adherence to treatment.
Area of Science:
- Hematology
- Patient Adherence Research
- Bleeding Disorder Management
Background:
- Prophylactic clotting-factor regimens are vital for managing moderate and severe hemophilia, preventing bleeds and maintaining joint health.
- Achieving optimal outcomes with prophylaxis is contingent upon patient adherence to prescribed treatment plans.
- Various patient, condition, treatment, healthcare system, and socioeconomic factors can act as barriers to adherence.
Purpose of the Study:
- To highlight the critical role of adherence in the success of prophylactic clotting-factor regimens for hemophilia.
- To identify common barriers to adherence encountered by patients with hemophilia.
- To emphasize the need for personalized, patient-centered strategies to improve adherence to prophylactic therapy.
Main Methods:
- Literature review and synthesis of existing research on hemophilia prophylaxis and adherence barriers.
- Analysis of factors influencing healthcare professionals' decisions to prescribe prophylaxis.
- Discussion of strategies to enhance patient and family engagement and confidence in treatment administration.
Main Results:
- Adherence is essential for prophylaxis efficacy in hemophilia, impacting bleeding episodes and joint health.
- Perceived patient nonadherence can deter healthcare professionals from prescribing prophylaxis.
- Individualized treatment goals and tailored adherence strategies are necessary for successful long-term management.
Conclusions:
- Developing personalized prophylactic treatment strategies in collaboration with patients and families is key.
- Reinforcing the importance and building confidence in regular infusions through various informational channels can improve adherence.
- Emerging extended half-life clotting factors may offer a promising avenue to enhance adherence due to less frequent administration requirements.